PT-141, also known as Bremelanotide, is a synthetic hormone used to treat sexual arousal disorder and erectile dysfunction. It works by activating the melanocortin receptors in the brain that are responsible for sexual excitement and arousal.
Some key points about PT-141:
- It is administered as a nasal spray or injection. The effects typically last between 1-2 hours.
- PT-141 was originally developed by Palatin Technologies. In 2019, AMAG Pharmaceuticals acquired the North American rights and now markets it under the brand name Vyleesi.
- Unlike Viagra which acts on the vascular system, PT-141 works centrally on the nervous system to modulate neurotransmitters and hormones involved in sexual response.
- It can be an effective treatment for both men and women suffering from low libido or sexual desire. Clinical trials have shown improved scores in arousal, desire and number of satisfying sexual events.
- The most common side effects are nausea, flushing, headache and vomiting. It should be used with caution in people with cardiovascular disease or risk factors.
While more research is still needed, PT-141 provides a promising new avenue for managing various sexual dysfunction disorders. At Butterfly Hormone Center, we offer cutting-edge options like Vyleesi for patients struggling with sexual health and intimacy issues in their relationships. Our compassionate providers carefully evaluate each individual to determine the safest and most effective treatments to meet their goals. We empower our patients with the knowledge, tools and support needed to improve confidence and quality of life. Please () or call to schedule a consultation.